We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNR
2176
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $1.17M | ﹤0.01% |
132,704
-17,906
| -12% | -$123K |
|
|
TRTX
2177
TPG RE Finance Trust
TRTX
$618M
| $1.16M | ﹤0.01% |
86,290
-9,973
| -10% | -$128K |
|
|
GBIO
2178
DELISTED
Generation Bio
GBIO
| $1.16M | ﹤0.01% |
4,314
+94
| +2% | +$28.1K |
|
2179
Peoples Bancorp
PEBO
$1.47B
| $1.16M | ﹤0.01% |
39,176
-3,862
| -9% | -$126K |
|
2180
Madrigal Pharmaceuticals
MDGL
$11.8B
| $1.16M | ﹤0.01% |
11,879
+1,454
| +14% | +$172K |
|
2181
Seneca Foods Class A
SENEA
$1.21B
| $1.16M | ﹤0.01% |
22,646
-1,135
| -5% | -$54.8K |
|
|
FFIC
2182
DELISTED
Flushing Financial
FFIC
| $1.15M | ﹤0.01% |
53,616
-4,481
| -8% | -$101K |
|
2183
Cerus
CERS
$474M
| $1.14M | ﹤0.01% |
193,517
-14,002
| -7% | -$82.1K |
|
2184
Utz Brands
UTZ
$1.25B
| $1.14M | ﹤0.01% |
+52,491
| New | +$1.31M |
|
2185
Univest Financial
UVSP
$1.18B
| $1.14M | ﹤0.01% |
43,264
-4,919
| -10% | -$138K |
|
2186
Ingles Markets
IMKTA
$1.67B
| $1.14M | ﹤0.01% |
19,547
-2,859
| -13% | -$177K |
|
2187
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $1.14M | ﹤0.01% |
40,907
-10,351
| -20% | -$283K |
|
2188
Orion
OEC
$409M
| $1.13M | ﹤0.01% |
59,487
-18,228
| -23% | -$361K |
|
|
GOOD
2189
Gladstone Commercial Corp
GOOD
$627M
| $1.13M | ﹤0.01% |
49,901
-4,347
| -8% | -$92.9K |
|
|
HEES
2190
DELISTED
H&E Equipment Services
HEES
| $1.13M | ﹤0.01% |
33,843
-18,316
| -35% | -$671K |
|
2191
Argan
AGX
$8.37B
| $1.12M | ﹤0.01% |
23,471
-2,453
| -9% | -$122K |
|
2192
Cato Corp
CATO
$66.1M
| $1.12M | ﹤0.01% |
66,252
-5,199
| -7% | -$76.9K |
|
2193
Upland Software
UPLD
$15.4M
| $1.12M | ﹤0.01% |
2,715
-105
| -4% | -$46.2K |
|
|
MORF
2194
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $1.12M | ﹤0.01% |
19,486
+6,278
| +48% | +$345K |
|
2195
El Pollo Loco
LOCO
$462M
| $1.11M | ﹤0.01% |
60,847
-3,245
| -5% | -$55.5K |
|
2196
Omeros
OMER
$959M
| $1.11M | ﹤0.01% |
74,846
+5,629
| +8% | +$94.5K |
|
2197
StepStone Group
STEP
$3.82B
| $1.11M | ﹤0.01% |
32,288
+10,344
| +47% | +$344K |
|
2198
Schneider National
SNDR
$6.25B
| $1.11M | ﹤0.01% |
50,997
-7,463
| -13% | -$181K |
|
|
UMH
2199
UMH Properties
UMH
$1.36B
| $1.11M | ﹤0.01% |
50,706
-2,923
| -5% | -$62.3K |
|
|
EPZM
2200
DELISTED
Epizyme, Inc
EPZM
| $1.1M | ﹤0.01% |
132,530
-18,576
| -12% | -$157K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.